Lucid Diagnostics makes EsoGuard, a DNA test that screens for precancerous changes in the esophagus in people with chronic heartburn. It last closed at $0.40 on Nov 17, up 0.30% on the day. The average 12-month price target from 2 analysts is $6.00 (+1403.8% from the last close), with a high of $9.50 and a low of $2.50.
Only 2 firms rated LUCD in the past 90 days, not enough for a consensus
Average 12-month target
$6.00
▲ 1403.8% upside
Based on 2 analysts who set a price target on LUCD in the past 90 days. The average target is $6.00, with a high of $9.50 and a low of $2.50, compared with the last close of $0.40.
Low $2.50Avg $6.00High $9.50
Blue marker: last close $0.40
Highest target$9.50
Average target$6.00
Lowest target$2.50
Latest rating changes
BTIGReiterated
Oct 23Buy$2.50
Ascendiant CapitalTarget raised
Aug 27Buy$9.25 → $9.50
Ascendiant CapitalMaintained
Jun 8Buy$9.25
Date
Firm
Action
Rating
Price target
Oct 23
BTIG
Reiterated
Buy
$2.50
Aug 27
Ascendiant Capital
Target raised
Buy
$9.25 → $9.50
Jun 8
Ascendiant Capital
Maintained
Buy
$9.25
Loading…
Technical Analysis
LUCD · as of the Nov 17 close · updated after every close
Downtrend
The stock is 3% below its 20 day and 45% below its 50 day average. It is 145% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 42). The nearest support is the Pivot at $0.39, and the nearest resistance the Pivot R1 at $0.41.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 14.4%/day
Key levels
$1.6352 week high+307.5%
$0.98200 day average+145.0%
$0.78100 day average+95.0%
$0.5850 day average+45.0%
$0.48Swing high (Nov 4)+20.0%
$0.4120 day average+2.5%
$0.41Pivot R1+2.5%
$0.40Last close
$0.39Pivot−2.5%
$0.38Pivot S1−5.0%
$0.38Swing low (Oct 28)−5.0%
$0.3052 week low−25.0%
Indicators
RSI (14)
41.69
Middle of its range
Neutral
MACD
-0.05
Above its signal line
Bullish
Stochastic
30.7
Middle of its range
Neutral
ADX (14)
15.9
No clear trend
Williams %R
-76.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-59.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.3%
Change over 10 sessions
Bearish
ATR (14)
$0.06
Typical daily range, 14.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 34.7%/day
Key levels
$1.6352 week high+307.5%
$0.98200 day average+145.0%
$0.78100 day average+95.0%
$0.5850 day average+45.0%
$0.48Swing high (Nov 4)+20.0%
$0.4120 day average+2.5%
$0.41Pivot R1+2.5%
$0.40Last close
$0.39Pivot−2.5%
$0.38Pivot S1−5.0%
$0.38Swing low (Oct 28)−5.0%
$0.3052 week low−25.0%
Indicators
RSI (14)
26.11
Oversold below 30
Oversold
MACD
-0.17
Below its signal line
Bearish
Stochastic
15.5
Near the bottom of its range
Oversold
ADX (14)
23.1
Weak trend
Williams %R
-87.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-109.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−49.0%
Change over 10 sessions
Bearish
ATR (14)
$0.14
Typical daily range, 34.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for LUCD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LUCD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow LUCD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How LUCD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LUCD is in one of them and how their past LUCD trades turned out.
Lucid Diagnostics is a medical diagnostics company based in New York. Its main product is EsoGuard, a DNA test that looks for precancerous changes in the esophagus, run on cell samples collected with the EsoCheck swallowable capsule device. The company targets people with chronic heartburn, also known as GERD, who are at risk of esophageal cancer, and it offers testing through its own test centers, mobile units, physician office programs and health system arrangements.